Skip to content

Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer

Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02202655
Acronym
NSCLC
Enrollment
50
Registered
2014-07-29
Start date
2014-05-31
Completion date
2015-09-30
Last updated
2014-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small Cell Lung Cancer

Keywords

non- small cell lung cancer;, lymphocyte subsets

Brief summary

The purpose of this study is to investigate the changes of lymphocyte subsets in chemotherapy course of patients with non-small cell lung cancer

Detailed description

patients with primary non-small cell lung cancer who received first chemotherapy in Beijing Chaoyang Hospital affiliated to Capital Medical University were collected, and the percentage of lymphocyte subsets at 9 time points before, during, and after chemotherapy was detected by flow cytometry method.We will investigate the changes of patients' lymphocyte subsets in chemotherapy courses. The correlation of the percentage of lymphocyte subsets and age, gender, pathological type, clinical stage, surgery or not, clinical efficacy assessment will be further analyzed.

Interventions

None listed

Sponsors

Beijing Chao Yang Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Each Period Non-small Cell Lung Cancer, Which Was Confirmed by Histopathology. patients has only lung cancer . * Functional Status Score (PS) ≧ 70. * The first time for chemotherapy . * A Written Informed Consent.

Exclusion criteria

* Merging other tumors. * HAve autoimmune diseases. * AIDS

Design outcomes

Primary

MeasureTime frame
the changes of patients' lymphocyte subsets in chemotherapy courses.up to cycle 4 day 9

Countries

China

Contacts

Primary Contactqian wang, master
wenqian.3334444@163.com18810252602

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026